Carnitine Insufficiency Is Associated With Fatigue During Lenvatinib Treatment in Patients With Hepatocellular Carcinoma

PLoS ONE - United States
doi 10.1371/journal.pone.0229772
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Journal of Gastroenterology
Gastroenterology
2016English

Radiation-Related Lymphopenia Is Associated With Spleen Irradiation Dose During Radiotherapy in Patients With Hepatocellular Carcinoma

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

The Three Criteria for Radiological Response on Survival in Patients With Hepatocellular Carcinoma Treated With Lenvatinib

Hepatology Research
HepatologyInfectious Diseases
2019English

Lenvatinib and Its Use in the Treatment of Unresectable Hepatocellular Carcinoma

Future Oncology
MedicineCancer ResearchOncology
2018English

Positive Expression of SMYD2 Is Associated With Poor Prognosis in Patients With Primary Hepatocellular Carcinoma

Journal of Cancer
Oncology
2018English

EIF4EBP1 Overexpression Is Associated With Poor Survival and Disease Progression in Patients With Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2015English

Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Overexpression of Cullin7 Is Associated With Hepatocellular Carcinoma Progression and Pathogenesis

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Unexpected Viral Relapses in Hepatitis C Virus-Infected Patients Diagnosed With Hepatocellular Carcinoma During Treatment With Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy